pubmed-article:16799889 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16799889 | lifeskim:mentions | umls-concept:C0220847 | lld:lifeskim |
pubmed-article:16799889 | lifeskim:mentions | umls-concept:C0042769 | lld:lifeskim |
pubmed-article:16799889 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:16799889 | lifeskim:mentions | umls-concept:C0238598 | lld:lifeskim |
pubmed-article:16799889 | lifeskim:mentions | umls-concept:C0021747 | lld:lifeskim |
pubmed-article:16799889 | lifeskim:mentions | umls-concept:C0524910 | lld:lifeskim |
pubmed-article:16799889 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:16799889 | pubmed:dateCreated | 2006-6-26 | lld:pubmed |
pubmed-article:16799889 | pubmed:abstractText | Suppression of the progression to cirrhosis and hepatocellular carcinoma is important, especially for young hepatitis C virus (HCV)-infected patients. The aim of this study was to analyze the response to interferon (IFN) monotherapy in young HCV patients. | lld:pubmed |
pubmed-article:16799889 | pubmed:language | eng | lld:pubmed |
pubmed-article:16799889 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16799889 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16799889 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16799889 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16799889 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16799889 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16799889 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16799889 | pubmed:month | May | lld:pubmed |
pubmed-article:16799889 | pubmed:issn | 0944-1174 | lld:pubmed |
pubmed-article:16799889 | pubmed:author | pubmed-author:KumadaHiromit... | lld:pubmed |
pubmed-article:16799889 | pubmed:author | pubmed-author:IkedaKenjiK | lld:pubmed |
pubmed-article:16799889 | pubmed:author | pubmed-author:AraseYasujiY | lld:pubmed |
pubmed-article:16799889 | pubmed:author | pubmed-author:SuzukiYoshiyu... | lld:pubmed |
pubmed-article:16799889 | pubmed:author | pubmed-author:SaitohSatoshi... | lld:pubmed |
pubmed-article:16799889 | pubmed:author | pubmed-author:KobayashiMasa... | lld:pubmed |
pubmed-article:16799889 | pubmed:author | pubmed-author:SuzukiFumitak... | lld:pubmed |
pubmed-article:16799889 | pubmed:author | pubmed-author:AkutaNorioN | lld:pubmed |
pubmed-article:16799889 | pubmed:author | pubmed-author:SomeyaTakashi... | lld:pubmed |
pubmed-article:16799889 | pubmed:author | pubmed-author:HosakaTetsuya... | lld:pubmed |
pubmed-article:16799889 | pubmed:author | pubmed-author:SezakiHitomiH | lld:pubmed |
pubmed-article:16799889 | pubmed:author | pubmed-author:UkaKiminoriK | lld:pubmed |
pubmed-article:16799889 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16799889 | pubmed:volume | 41 | lld:pubmed |
pubmed-article:16799889 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16799889 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16799889 | pubmed:pagination | 470-5 | lld:pubmed |
pubmed-article:16799889 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:16799889 | pubmed:meshHeading | pubmed-meshheading:16799889... | lld:pubmed |
pubmed-article:16799889 | pubmed:meshHeading | pubmed-meshheading:16799889... | lld:pubmed |
pubmed-article:16799889 | pubmed:meshHeading | pubmed-meshheading:16799889... | lld:pubmed |
pubmed-article:16799889 | pubmed:meshHeading | pubmed-meshheading:16799889... | lld:pubmed |
pubmed-article:16799889 | pubmed:meshHeading | pubmed-meshheading:16799889... | lld:pubmed |
pubmed-article:16799889 | pubmed:meshHeading | pubmed-meshheading:16799889... | lld:pubmed |
pubmed-article:16799889 | pubmed:meshHeading | pubmed-meshheading:16799889... | lld:pubmed |
pubmed-article:16799889 | pubmed:meshHeading | pubmed-meshheading:16799889... | lld:pubmed |
pubmed-article:16799889 | pubmed:meshHeading | pubmed-meshheading:16799889... | lld:pubmed |
pubmed-article:16799889 | pubmed:meshHeading | pubmed-meshheading:16799889... | lld:pubmed |
pubmed-article:16799889 | pubmed:meshHeading | pubmed-meshheading:16799889... | lld:pubmed |
pubmed-article:16799889 | pubmed:meshHeading | pubmed-meshheading:16799889... | lld:pubmed |
pubmed-article:16799889 | pubmed:meshHeading | pubmed-meshheading:16799889... | lld:pubmed |
pubmed-article:16799889 | pubmed:meshHeading | pubmed-meshheading:16799889... | lld:pubmed |
pubmed-article:16799889 | pubmed:meshHeading | pubmed-meshheading:16799889... | lld:pubmed |
pubmed-article:16799889 | pubmed:meshHeading | pubmed-meshheading:16799889... | lld:pubmed |
pubmed-article:16799889 | pubmed:meshHeading | pubmed-meshheading:16799889... | lld:pubmed |
pubmed-article:16799889 | pubmed:meshHeading | pubmed-meshheading:16799889... | lld:pubmed |
pubmed-article:16799889 | pubmed:meshHeading | pubmed-meshheading:16799889... | lld:pubmed |
pubmed-article:16799889 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16799889 | pubmed:articleTitle | Efficacy of interferon monotherapy in young adult patients with chronic hepatitis C virus infection. | lld:pubmed |
pubmed-article:16799889 | pubmed:affiliation | Department of Gastroenterology, Toranomon Hospital, Minato-ku, Tokyo, Japan. | lld:pubmed |
pubmed-article:16799889 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16799889 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |